Literature DB >> 31127465

Genetic factors affecting thrombosis in patients with essential thrombocythemia by heparin treatment.

Tomoyuki Kawada1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31127465     DOI： 10.1007/s11239-019-01886-x

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  5 in total

1.  Increased risk of heparin induced thrombocytopenia and thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation.

Authors:  Roberto Castelli; Paolo Gallipoli; Riccardo Schiavon; Thomas Teatini; Giorgio Lambertenghi Deliliers; Luigi Bergamaschini
Journal:  J Thromb Thrombolysis       Date:  2019-01       Impact factor: 2.300

2.  Once- versus twice-daily aspirin treatment in patients with essential thrombocytosis.

Authors:  Mads Lamm Larsen; Oliver Heidmann Pedersen; Anne-Mette Hvas; Peter Buur van Kooten Niekerk; Søren Bønløkke; Steen Dalby Kristensen; Erik Lerkevang Grove
Journal:  Platelets       Date:  2018-02-14       Impact factor: 3.862

Review 3.  Anagrelide compared with hydroxyurea in essential thrombocythemia: a meta-analysis.

Authors:  Bethany Samuelson; Chatree Chai-Adisaksopha; David Garcia
Journal:  J Thromb Thrombolysis       Date:  2015-11       Impact factor: 2.300

4.  Impact of white blood cells on thrombotic risk in patients with optimized platelet count in essential thrombocythemia.

Authors:  Veronika Buxhofer-Ausch; Michael Steurer; Siegfried Sormann; Ernst Schloegl; Wolfgang Schimetta; Bettina Gisslinger; Martin Schalling; Maria Theresa Krauth; Jürgen Thiele; Reinhard Ruckser; Günther Gastl; Heinz Gisslinger
Journal:  Eur J Haematol       Date:  2018-03-30       Impact factor: 2.997

5.  Clinico-hematological profile and thrombotic/hemorrhagic events in 150 chinese patients with essential thrombocythemia.

Authors:  Dian Zhou; Wei Chen; Hai Cheng; Jian-Lin Qiao; Li-Li Zhu; Zhen-Yu Li; Kai-Lin Xu
Journal:  Leuk Res       Date:  2018-03-27       Impact factor: 3.156
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.